Cargando…
Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies
BACKGROUND: A549 carrier cells infected with oncolytic adenovirus can induce complete tumor reduction of subcutaneous ovarian tumors but not intraperitoneal disseminated ovarian tumors. This appears to be a result of the insufficient antitumor effect of A549 carrier cells. Therefore, in the present...
Autores principales: | Hamada, Katsuyuki, Takagi, Soichi, Kuboshima, Hajime, Shimada, Hideaki, Takagi, Kazuko, Yasuoka, Toshiaki, Matsubara, Keiichi, Sassa, Yukiko, Furuya, Tetsuya, Suzuki, Kazuhiko, Uchide, Tsuyoshi, Mizutani, Tetsuya, Tani, Kenzaburo, Itoh, Hiroshi, Sugiyama, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590659/ https://www.ncbi.nlm.nih.gov/pubmed/30548997 http://dx.doi.org/10.1002/jgm.3064 |
Ejemplares similares
-
Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter
por: Hamada, Katsuyuki, et al.
Publicado: (2014) -
Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020) -
Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer
por: Toyoda, Eiji, et al.
Publicado: (2008) -
A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity
por: Nosaki, Kaname, et al.
Publicado: (2016) -
Oncolytic effect of Midkine promoter–based conditionally replicating adenoviruses expressing EGFR siRNA in head and neck squamous cancer cell line T891
por: Uehara, Natsumi, et al.
Publicado: (2020)